Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of somatropin on left ventricular mass in adults with growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 4 | Status: COMPLETED